Our customers and the microbiome market at large have expressed interest in research use only method for the study of SARS-CoV-2, the virus that causes COVID-19. Diversigen has updated its viral metagenomics pipeline for the detection of SARS-CoV-2. This pipeline can detect SARS-CoV-2 in confirmed positive samples and it can differentiate between coronavirus species. In addition the pipeline can be used to recover the SARS-CoV-2 genome at a depth and coverage that allows for genome assembly, which is crucial for strain and/or mutation rate tracking. In addition to the commonly used nasal nasopharyngeal samples, there are reports that SARS-CoV-2, can be detected in samples that are often of interest to microbiome researchers, including saliva and feces; the pipeline is compatible with these three samples types, and others. Diversigen has an experienced, dedicated team ready to help you in these challenging times. Connect with our scientific advisors today using the Live Chat feature.